Carnegie Capital Asset Management, LLC Astrazeneca PLC Transaction History
Carnegie Capital Asset Management, LLC
- $3.38 Billion
- Q4 2024
A detailed history of Carnegie Capital Asset Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 16,492 shares of AZN stock, worth $1.17 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
16,492
Previous 17,338
4.88%
Holding current value
$1.17 Million
Previous $1.35 Million
20.0%
% of portfolio
0.03%
Previous 0.04%
Shares
19 transactions
Others Institutions Holding AZN
# of Institutions
1,340Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.45 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.97 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.64 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.61 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.35 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $219B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...